Cost analysis of oral antidepressant drugs available in India
Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2015, Vol 5, Issue 5
Abstract
Background: Depression is a disorder that disrupts the public health through factors such as its occurrence, distress, ill health, and economic burden. There is a wide variation in the prices of antidepressant drugs marketed in India. Aims and Objective: To find out the price variations in the oral antidepressant drugs available in India either as a single drug or in combination and to evaluate the differences in the cost of various brands of the same oral antidepressant drug by calculating the percentage variation in cost in Indian rupees. Materials and Methods: The cost of a particular drug being manufactured by different companies, in the same strength and dosage forms, was obtained from ‘‘Current Index of Medical Specialties’’ July–October, 2014, and ‘‘Indian Drug Review, 2014;21(4)’’. The difference between the maximum and minimum prices of the same drug and the percentage variation in the prices was calculated. Result: The prices of a total of 25 drugs (21 single and 4 combination preparations) available in 66 different formulations were analyzed. In single drug therapy, among tricyclic antidepressants, reboxetine (2 mg) showed the maximum price variation of 900%. In atypical antidepressants, bupropion hydrochloride (150 mg) showed the maximum price variation of 447.94%. In selective serotonin reuptake inhibitors (SSRIs), paroxetine (37.5 mg) showed the maximum price variation of 1116.66%. In serotonin norepinephrine reuptake inhibitors (SNRIs), Venlafaxine hydrochloride (37.5 mg) showed the maximum price variation of 246.15%. In monoamine oxidase (MAO)-A inhibitors, moclobemide (150 mg) showed the maximum price variation of 246.15%. In combination therapies, chlordiazepoxide with amitriptyline showed the maximum price variation of 227.23%. Conclusion: The average percentage variations of different brands of the same drug manufactured in India is very wide. The management of the marketing drugs should be directed toward maximizing the therapeutic benefits to the community and minimizing the economic burden.
Authors and Affiliations
Abhinay P Paunikar, Kiran A Bhave
Keywords
Related Articles
- EP ID EP118004
- DOI 10.5455/njppp.2015.5.1105201556
- Views 118
- Downloads 0
Brainstem evoked auditory response in preterm and full-term infants
Background: The survival of preterm infants has increased substantially over last few decades because of improvements in obstetric and neonatal care. However, the newborn experience many perinatal complica...
Clinical profile of chronic daily headache in patient attending tertiary centre
Background: The frequent headache syndrome is among the most challenging disorder that conforms clinician on a routine basis. A major problem with the relatively new form chronic daily headache (CDH) has been its confusi...
Description of physical fitness, blood glucose, and cholesterol levels of the middle age operational workers in transportation company
Background: Physical fitness (PF) is a key to maintain company productivity. The transportation company has complicated jobs and high physical demand. Aging, obesity, and sedentary lifestyle can decrease PF and work prod...
Immediate effects of mobile phone radiations on heart rate variability in college going students
Background: The use of mobile phone has increased excessively these days which can have a deleterious effect on human tissues and organs, especially cardiovascular system (CVS). The effects on CVS can be detected at an e...
Visual evoked potential changes among security guards of Government Medical College and New Civil Hospital, Surat
Background: Sleep interruption and disturbance of circadian rhythm are inevitable phenomena among night shift workers. A very few evidence is available that describing effects of sleep disturbance and its effect on the v...